Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients

American Journal Geriatric Pharmacotherapy

Volumn 6, Issue 4, 2008, Pages 198-204

  Aparasu, Rajender R ^a   Jano, Elda ^a   Johnson, Michael L ^a   Chen, Hua ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

antipsychotic; atypical; elderly; hospitalization; risk; typical

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PROMAZINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; ZIPRASIDONE;

AGE; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; ELDERLY CARE; FEMALE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PHARMACEUTICAL CARE; POPULATION RISK; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DRUG THERAPY; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PSYCHOTIC DISORDERS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; RISK; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 56349170740     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2008.10.003     Document Type: Article

References (36)

1. Arana G.W. An overview of side effects caused by typical antipsychotics. J Clin Psychiatry 61 Suppl 8 (2000) 5-11
2. Masand P.S. Side effects of antipsychotics in the elderly. J Clin Psychiatry 61 Suppl 8 (2000) 43-49
3. Correll C.U., Leucht S., and Kane J.M. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies. Am J Psychiatry 161 (2004) 414-425
4. Jano E., Chen H., Johnson M.L., and Aparasu R.R. Antipsychotic utilization and expenditure trends among elderly persons. Psychiatr Serv 58 (2007) 1400
5. Jano E., Johnson M., Chen H., and Aparasu R.R. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004. Curr Med Res Opin 24 (2008) 709-716
6. Aparasu R.R., Bhatara V., and Gupta S. U.S. national trends in the use of antipsychotics during office visits, 1998-2002. Ann Clin Psychiatry 117 (2005) 147-152
7. Rapoport M., Mamdani M., Shulman K.I., et al. Antipsychotic use in the elderly: Shifting trends and increasing costs. Int J Geriatr Psychiatry 20 (2005) 749-753
8. Lieberman J.A., Stroup T.S., McEvoy J.P., et al., Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353 (2005) 1209-1223
9. Rush A.J., Pincus H.A., First M.B., and Blacker E. Handbook of Psychiatric Measures. 1st ed. (2000), American Psychiatric Association, Washington, DC
10. Schneider L.S., Tariot P.N., Dagerman K.S., et al., CATIE-AD Study Group. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 355 (2006) 1525-1538
11. Shekelle M., Maglione, Bagley S., et al. Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics. Comparative Effectiveness Review No. 6 (2007), Agency for Healthcare Research and Quality, Rockville, Md
12. Deaths with antipsychotics in elderly patients with behavioral disturbances. FDA public health advisory. [FDA Web site] (June 27, 2008). http://www.fda.gov/cder/drug/advisory/antipsychotics.htm Accessed
13. Markowitz J.S., Brown C.S., and Moore T.R. Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 33 (1999) 73-85
14. Jin H., Meyer J.M., and Jeste D.V. Atypical antipsychotics and glucose dysregulation: A systematic review. Schizophr Res 71 (2004) 195-212
15. Carson S., McDonagh M.S., and Peterson K. A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia. [published correction appears in J Am Geriatr Soc. 2006;54:1479]. J Am Geriatr Soc. 54 (2006) 354-361
16. Liperoti R., Gambassi G., Lapane K.L., et al. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. J Clin Psychiatry 66 (2005) 1090-1096
17. Liperoti R., Gambassi G., Lapane K.L., et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med 165 (2005) 696-701
18. Liperoti R., Pedone C., Lapane K.L., et al. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med 165 (2005) 2677-2682
19. Herrmann N., Mamdani M., and Lanctôt K.L. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161 (2004) 1113-1115
20. Hien le T.T., Cumming R.G., Cameron I.D., et al. Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J Am Geriatr Soc 53 (2005) 1290-1295
21. Gill S.S., Rochon P.A., Herrmann N., et al. Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. BMJ 330 (2005) 445
22. Percudani M., Barbui C., Fortino I., et al. Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly. J Clin Psychopharmacol 25 (2005) 468-470
23. Salkever D.S., Slade E.P., Karakus M., et al. Estimation of antipsychotic effects on hospitalization risk in a naturalistic study with selection on unobservables. J Nerv Ment Dis 192 (2004) 119-128
24. Finkel S., Kozma C., Long S., et al. Risperidone treatment in elderly patients with dementia: Relative risk of cerebrovascular events versus other antipsychotics. Int Psychogeriatr 17 (2005) 617-629
25. Cohen S.B. Sample design of the 1996 Medical Expenditure Panel Survey Household Component. [Agency for Healthcare Research and Quality Web site] (June 27, 2008). http://www.meps.ahrq.gov/data_files/publications/mr2/mr2.shtml Accessed
26. Medical Expenditure Panel Survey: Survey Background. [Agency for Healthcare Research and Quality Web site] (June 27, 2008). http://www.meps.ahrq.gov/mepseb/about_meps/survey_back.jsp Accessed
27. Medical Expenditure Panel Survey: Survey Questionnaires-Household Component (June 27, 2008), Agency for Healthcare Research and Quality, Rockville, Md. www.meps.ahrq.gov/mepsweb/survey_comp/survey.jsp Accessed
28. Moeller J.F., Stagnitti M.N., and Horan E. Outpatient Prescription Drugs: Data Collection and Editing in the 1996 Medical Expenditure Survey (HC-010A). MEPS Methodology Report No. 12. AHRQ Pub. No. 01-0002 (2001), Agency for Healthcare Research and Quality, Rockville, Md
29. MEPS Household Component Weighting & Estimation Issues. [Agency for Healthcare Research and Quality Website] (June 27, 2008). http://www.meps.ahrq.gov/mepsweb/about_meps/workbook/WB-Weight_Estimat.pdf Accessed
30. Cerner Multum Lexicon Guide. [Cerner Multum Web site] (June 27, 2008). http://www.multum.com/LexGuide.pdf Accessed
31. Zuckerman I.H., Langenberg P., Baumgarten M., et al. Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med Care 44 (2006) 722-730
32. Wagner A.K., Zhang F., Soumerai S.B., et al. Benzodiazepine use and hip fractures in the elderly: Who is at greatest risk?. Arch Intern Med 164 (2004) 1567-1572
33. Ensrud K.E., Blackwell T., Mangione C.M., et al., Study of Osteoporotic Fractures Research Group. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163 (2003) 949-957
34. Saltz B.L., Robinson D.G., and Woerner M.G. Recognizing and managing antipsychotic drug treatment side effects in the elderly. Prim Care Companion J Clin Psychiatry 6 Suppl 2 (2004) 14-19
35. Fuller G.F. Falls in the elderly. Am Fam Physician 61 (2000) 2159-2168
36. Fuller G.F. Falls in the elderly. Am Fam Physician 61 (2000) 2173-2174